Science ❯ Biology

Pharmacology

Drug Development Neuropharmacology Drug Delivery Drug Discovery Cannabinoids Cannabis Cancer Treatment Drug Absorption Cancer Treatment Technologies Medicinal Chemistry Plant Extracts Isoxazolines Antibiotics GLP-1 Drugs Drug Mechanisms Psychoactive Substances Psychedelic Drugs Drug Effects HIV Prevention Drug Sensitivity Neuropeptides Cancer Biology GLP-1 Receptor Agonists

Novo Nordisk Licenses Vivtex Platform in $2.1 Billion Push for Oral Obesity and Diabetes Drugs

The pact taps an AI-enabled gut-on-a-chip platform to turn injectable peptides into pills in a crowded GLP-1 market.

NCI Pursues Preclinical Test of Ivermectin’s Anti-Cancer Activity

FDA Approves Vanda’s Nereus, First New Motion Sickness Treatment in Over 40 Years

Study Finds CBD–THC Combination Kills Ovarian Cancer Cells in Lab

Lilly Steps Up Obesity Push With San Diego Innovation Hub and $6.5 Billion Houston Factory

FDA Approves Bravecto Quantum Injectable for Year-Long Flea and Tick Prevention